Embryo Biopsy for PGS/PGD is a crucial step in Assisted Reproductive Technology (ART), allowing fertility specialists to analyze embryos at the genetic level. Through this technique, SCI IVF Hospital can identify chromosomal abnormalities or genetic disorders, thereby improving the likelihood of a successful pregnancy and a healthy baby.

Dr. Shivani Sachdev Gour, Director of SCI IVF Hospital, commented, “Our mission is to provide state-of-the-art fertility treatments that increase success rates and provide hope to couples facing infertility. The introduction of Embryo Biopsy for PGS/PGD demonstrates our commitment to excellence and patient care.”

The process involves extracting a few cells from the embryo and thoroughly examining them for genetic conditions before implantation. It is especially beneficial for:

• Couples with a history of genetic disorders.

• Women of advanced maternal age.

• Recurrent IVF failures.

• Severe male factor infertility.

SCI IVF Hospital’s team of experts ensures that the procedure is carried out with the utmost precision and care. The hospital offers personalized treatment plans designed to meet the unique needs of each patient.

SCI IVF Hospital is a renowned fertility center based in Delhi, India, offering a wide range of infertility treatments, including IVF, IUI, ICSI, surrogacy, and advanced genetic testing. With a highly skilled team of fertility specialists and state-of-the-art facilities, SCI IVF Hospital continues to deliver successful outcomes for countless couples.